| Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines C Schauer, C Janko, LE Munoz, Y Zhao, D Kienhöfer, B Frey, M Lell, ... Nature medicine 20 (5), 511-517, 2014 | 922 | 2014 |
| Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection T HARRER, E HARRER, SA KALAMS, T ELBEIK, SI STAPRANS, ... AIDS research and human retroviruses 12 (7), 585-592, 1996 | 445 | 1996 |
| Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person … T Harrer, E Harrer, SA Kalams, P Barbosa, A Trocha, RP Johnson, ... Journal of immunology (Baltimore, Md.: 1950) 156 (7), 2616-2623, 1996 | 432 | 1996 |
| Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication A Schneidewind, MA Brockman, R Yang, RI Adam, B Li, S Le Gall, ... Journal of virology 81 (22), 12382-12393, 2007 | 387 | 2007 |
| Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus K Manger, B Manger, R Repp, M Geisselbrecht, A Geiger, A Pfahlberg, ... Annals of the rheumatic diseases 61 (12), 1065-1070, 2002 | 272 | 2002 |
| Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) S Rasa, Z Nora-Krukle, N Henning, E Eliassen, E Shikova, T Harrer, ... Journal of translational medicine 16, 1-25, 2018 | 262 | 2018 |
| Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program Mind Exchange Working Group, A Antinori, G Arendt, I Grant, S Letendre, ... Clinical Infectious Diseases 56 (7), 1004-1017, 2013 | 223 | 2013 |
| Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients C Wyen, H Hendra, M Vogel, C Hoffmann, H Knechten, NH Brockmeyer, ... Journal of antimicrobial chemotherapy 61 (4), 914-918, 2008 | 217* | 2008 |
| Improved tag-switch method reveals that thioredoxin acts as depersulfidase and controls the intracellular levels of protein persulfidation R Wedmann, C Onderka, S Wei, IA Szijártó, JL Miljkovic, A Mitrovic, ... Chemical science 7 (5), 3414-3426, 2016 | 193 | 2016 |
| Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ... Clinical infectious diseases 62 (5), 655-663, 2016 | 189 | 2016 |
| Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their … C Jassoy, T Harrer, T Rosenthal, BA Navia, J Worth, RP Johnson, ... Journal of virology 67 (5), 2844-2852, 1993 | 151 | 1993 |
| Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy I Hauber, D Bevec, J Heukeshoven, F Krätzer, F Horn, A Choidas, ... The Journal of clinical investigation 115 (1), 76-85, 2005 | 145 | 2005 |
| Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 … A Cozzi-Lepri, M Noguera-Julian, F Di Giallonardo, R Schuurman, ... Journal of antimicrobial chemotherapy 70 (3), 930-940, 2015 | 142 | 2015 |
| Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells. HJ Zweerink, MC Gammon, U Utz, SY Sauma, T Harrer, JC Hawkins, ... Journal of immunology (Baltimore, Md.: 1950) 150 (5), 1763-1771, 1993 | 142 | 1993 |
| Therapeutic Vaccination of HIV-1-Infected Patients on Haart with a Recombinant HIV-1 Nef-Expressing Mva: Safety, Immunogenicity and Influence on Viral Load … E Harrer, M Bäuerle, B Ferstl, P Chaplin, B Petzold, L Mateo, A Handley, ... Antiviral therapy 10 (2), 285-300, 2005 | 141 | 2005 |
| Alpha-lipoic acid is an effective inhibitor of human immuno-deficiency virus (HIV-1) replication A Baur, T Harrer, M Peukert, G Jahn, JR Kalden, B Fleckenstein Klinische Wochenschrift 69, 722-724, 1991 | 136 | 1991 |
| Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing … C Wyen, H Hendra, M Siccardi, M Platten, H Jaeger, T Harrer, S Esser, ... Journal of antimicrobial chemotherapy 66 (9), 2092-2098, 2011 | 129 | 2011 |
| Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps D Kienhöfer, J Hahn, J Stoof, JZ Csepregi, C Reinwald, V Urbonaviciute, ... JCI insight 2 (10), 2017 | 122 | 2017 |
| Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors H Walter, B Schmidt, K Korn, AM Vandamme, T Harrer, K Überla Journal of clinical virology 13 (1-2), 71-80, 1999 | 111 | 1999 |
| HIV Nef, paxillin, and Pak1/2 regulate activation and secretion of TACE/ADAM10 proteases JH Lee, S Wittki, T Bräu, FS Dreyer, K Krätzel, J Dindorf, ICD Johnston, ... Molecular cell 49 (4), 668-679, 2013 | 108 | 2013 |
